BACKGROUND Reimbursement policies for anti-cancer drugs vary among countries even though they rely on the same clinical evidence. We compared the pattern of publicly funded drug programs and analyzed major factors influencing the differences. METHODS We investigated reimbursement policies for 19 indications with targeted anti-cancer drugs that are used variably across ten countries. The avail...

Phytochemicals serve as a promising and effective research area with bright future. Researchers have faced serious challenge in designing developing an alternative, eco-friendly, biocompatible, cost-effective strategy greener way due to the rising incidence of cancer, expensive treatment, various limitations conventional therapy, high toxicity current anticancer drugs. Using Novel drug delivery...

An editorial in The Lancet Oncology stated “It could be argued that since access to—and resources for—cancer treatment are so limited in developing countries, the answer lies in a greater reliance on generic drugs.” We agree, but the real question is how best can such generic drug production be stimulated? India provides one model to answer this question. India encouraged generic production fi ...

INTRODUCTION Cancer is the second most common cause of death in Portugal, with 24.3% of these deaths caused by malignant neoplasms. The strong impact on lost productivity and rising treatment costs make cancer a priority. In order to understand, compare, and control costs by promoting transparency in the health system, it is vital to analyse the cost of oncological diseases. This study aims to ...

with the prevalence of every type of cancer increasing globally, the inability to treat and the severe side effects caused by chemotherapy and radiotherapy are some of the biggest problems facing cancer patients and their physicians.1many herbal medicines have replaced their chemical rivals; for example, emetine lost its ground to metronidazole as an amoebicidal agent, and digoxin has given its...

The POpulation HEalth Model (POHEM) lung cancer microsimulation model has provided a useful framework for calculating the cost of managing individual cases of lung cancer in Canada by stage, cell type, and treatment modality, as well as the total economic burden of managing all cases of lung cancer diagnosed in Canada. These data allow an estimation of the overall cost effectiveness of lung can...

We thank de Boer and vanBodegraven for their interest in our trial (1) and the important considerations about the potential use of allopurinol for the prevention of colorectal cancer (CRC) in subjects with inflammatory bowel disease (IBD). Allopurinol has been used in the treatment of IBD for several years, and recent data (2, 3) further underline the efficacy of this drug to increase the compl...